BANTHINE Drug Patent Profile
✉ Email this page to a colleague
When do Banthine patents expire, and what generic alternatives are available?
Banthine is a drug marketed by Shire and is included in one NDA.
The generic ingredient in BANTHINE is methantheline bromide. Additional details are available on the methantheline bromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BANTHINE?
- What are the global sales for BANTHINE?
- What is Average Wholesale Price for BANTHINE?
Summary for BANTHINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 394 |
| DailyMed Link: | BANTHINE at DailyMed |
US Patents and Regulatory Information for BANTHINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | BANTHINE | methantheline bromide | TABLET;ORAL | 007390-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
